Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of uniQure N.V (NASDAQ: QURE) closed at $14.47 in the last session, down -2.89% from day before closing price of $14.90. In other words, the price has decreased by -$2.89 from its previous closing price. On the day, 1.7 million shares were traded.
Ratios:
We take a closer look at QURE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.99 and its Current Ratio is at 11.99. In the meantime, Its Debt-to-Equity ratio is 15.22 whereas as Long-Term Debt/Eq ratio is at 15.11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Kapusta Matthew C sold 28,341 shares for $10.29 per share. The transaction valued at 291,629 led to the insider holds 651,454 shares of the business.
Abi-Saab Walid sold 1,350 shares of QURE for $13,891 on Mar 04 ’25. The Chief Medical Officer now owns 151,903 shares after completing the transaction at $10.29 per share. On Mar 04 ’25, another insider, KLEMT CHRISTIAN, who serves as the Chief Financial Officer of the company, sold 10,438 shares for $10.29 each. As a result, the insider received 107,407 and left with 217,730 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 39.22 while its Price-to-Book (P/B) ratio in mrq is 23.50.
Stock Price History:
Over the past 52 weeks, QURE has reached a high of $19.18, while it has fallen to a 52-week low of $3.73. The 50-Day Moving Average of the stock is 13.48%, while the 200-Day Moving Average is calculated to be 36.36%.
Shares Statistics:
A total of 54.70M shares are outstanding, with a floating share count of 49.67M. Insiders hold about 9.27% of the company’s shares, while institutions hold 90.43% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from 10.0 analysts. The consensus estimate for the next quarter is -$0.72, with high estimates of -$0.18 and low estimates of -$0.99.
Analysts are recommending an EPS of between -$2.28 and -$3.99 for the fiscal current year, implying an average EPS of -$3.01. EPS for the following year is -$2.54, with 10.0 analysts recommending between -$1.72 and -$3.0.
Revenue Estimates
A total of 13 analysts have provided revenue estimates for QURE’s current fiscal year. The highest revenue estimate was $99.41M, while the lowest revenue estimate was $1.42M, resulting in an average revenue estimate of $26.83M. In the same quarter a year ago, actual revenue was $26.06MBased on 13 analysts’ estimates, the company’s revenue will be $63.44M in the next fiscal year. The high estimate is $165.89M and the low estimate is $14.96M.
